Questo prodotto esiste ed è attivo ma non è nella lingua scelta in questo momento
|
Editors-in-Chief
Paul Aisen, MD (University of Southern California Alzheimer's Therapeutic Research Institute, San Diego, California, USA)
Sandrine Andrieu, MD, PhD (Toulouse III University-Paul Sabatier, INSERM CERPOP, Toulouse, France)
Rachelle Doody, MD, PhD (Houston, USA)
Serge Gauthier, CM, MD, FRCPC (McGill University Research Centre for Studies in Aging, Montreal, Quebec, Canada)
Jacques Touchon, MD, PhD (University of Montpellier, Montpellier, France)
Founding Editor
Bruno Vellas, MD, PhD (IHU HealthAge, Toulouse, France)
Associate Editors
Felipe A. Court, PhD (Mayor University Center for Integrative Biology, Providencia, Chile)
Jean-François Dartigues, MD, PhD (Centre INSERM, Bordeaux Population Health, Bordeaux, France)
Michael Grundman, MD (University of California San Diego, La Jolla, California, USA)
Ara S. Khachaturian, MD (The Campaign to Prevent Alzheimer's Disease, Rockville, USA)
Zaven Khachaturian, MD (The Campaign to Prevent Alzheimer's Disease, Rockville, USA)
Rachel Nosheny, PhD (UCSF Weill Institute for Neurosciences, San Francisco, California, USA)
Okonkwo Ozioma, PhD (University of Wisconsin-Madison, Madison, Wisconsin, USA)
Sebastian Palmqvist, MD, PhD (Lund University, Lund, Sweden)
Michael Rafii, MD, PhD (University of California San Diego, La Jolla, California, USA)
Robert Rissman, PhD (University of California San Diego, La Jolla, California, USA)
Marwan Sabbagh, MD (Barrow Neurological Institute, Phoenix, Arizona, USA)
Duygu Tosun, PhD (University of California San Francisco, San Francisco, California, USA)
Natalio Vita, PhD (Toulouse III University-Paul Sabatier, Toulouse, France)
Michael Weiner, MD (University of California San Francisco, San Francisco, California, USA)
The Journal of Prevention of Alzheimer'Disease (JPAD) is a e-only gold open access journal that publishes reviews, original research articles and short reports to improve the knowledge in the field of Alzheimer prevention including: neurosciences, biomarkers, imaging, epidemiology, public health, physical cognitive exercise, nutrition, risk and protective factors, drug development, trials design, and heath economic outcomes.
JPAD publishes also the meeting abstracts from the Clinical Trial on Alzheimer Disease - CTAD's event.
The Journal of Prevention of Alzheimer'Disease is indexed in MEDLINE, SCIE (WoS), Scopus, and ranked in its categories in the first quartile (Q1) in both SCIE (WoS) and Scopus databases.
The Journal of Prevention of Alzheimer'Disease (JPAD) is a e-only gold open access journal that publishes reviews, original research articles and short reports to improve the knowledge in the field of Alzheimer prevention including: neurosciences, biomarkers, imaging, epidemiology, public health, physical cognitive exercise, nutrition, risk and protective factors, drug development, trials design, and heath economic outcomes.
JPAD publishes also the meeting abstracts from the Clinical Trial on Alzheimer Disease - CTAD's event.
The Journal of Prevention of Alzheimer'Disease is indexed in MEDLINE, SCIE (WoS), Scopus, and ranked in its categories in the first quartile (Q1) in both SCIE (WoS) and Scopus databases.
EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.
Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.
Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.